Barrow receives a $105,600 grant to study neurofibromatosis

The Department of Defense Neurofibromatosis Research Program recently awarded Barrow Neurological Institute at St. Joseph's Hospital and Medical Center a one-year exploratory and developmental grant worth $105,600.

Researchers at Barrow will use the grant to investigate if gene defects in Neurofibromatosis 1 (NF1) disrupt the function of nerve cells and the movement of molecules from the cell body to the terminals where they are needed.

"This grant will help us study a new area of research in neurofibromatosis and might help us find a new target for treatment of NF1," says Vinodh Narayanan, M.D., senior staff investigator and pediatric neurogeneticist at Barrow.

Neurofibromatosis is a genetic disorder that is usually diagnosed in childhood and causes tumors to grow along nerves anywhere in the body. NF1 is a distinct type of the disease that causes tumors and developmental problems and is believed to be the most common neurological disorder caused by a single gene.

Dr. Narayanan and his team at Barrow treat many children with neurofibromatosis through Children's Rehabilitative Services at St. Joseph's. This provides a foundation for the hospital to develop new strategies to improve the treatment of the disease.


Contact: Carmelle Malkovich
St. Joseph's Hospital and Medical Center

Page: 1

Related biology news :

1. Barrow receives two grants worth a total of 900,000 from the ABRC
2. Barrow Neurological Institute Neuroimmunology Fellow receives $50,000 award
3. Barrow Neurological Institute neuroimmunology fellow receives $135,000 fellowship award
4. Discovery at Barrow localizes visual awareness
5. Researchers at Barrow Neurological Institute resolve 40-year eye movement, visibility controversy
6. Barrow researcher receives $965,000 grant to study nicotine and smoking cessation
7. Carnegie Mellons Peter Adams receives EPA research grant
8. Philadelphia ecologist receives top Mongolia honor
9. VIB scientist receives major research grant
10. Maynard Olson receives $500,000 Gruber Genetics Prize
11. University of Cincinnati receives $1.7M to research molecular treatment of brain injury

Post Your Comments:

(Date:5/30/2020)... ... May 29, 2020 , ... ... for enterprises globally, has collaborated with EchoNous Inc. to develop the cloud-based connected ... measure systolic heart function, which has been clinically tested versus expert measurements, yielding ...
(Date:5/26/2020)... ... May 26, 2020 , ... ... R&D, today announced that Gritstone Oncology, Inc., a clinical-stage biotechnology company developing ... engagers and TCR-based therapeutics, has implemented Genedata Biologics ® within their ...
(Date:5/21/2020)... ... 2020 , ... Law Enforcement has always been a highly stressful career – ... of these men and women put them constantly in harm’s way both from the ... have always had to face very high daily stress. Now, COVID-19 introduces another even ...
Breaking Biology News(10 mins):
(Date:5/26/2020)... ... 2020 , ... Brilliant , the leading smart home control and lighting ... announce a new integration to bring more convenience, simplicity, and security to the smart ... Connect® can now be controlled from Brilliant’s in-wall touchscreen control panels and mobile app. ...
(Date:5/21/2020)... ... May 20, 2020 , ... ... Simon Prakash, who will serve as the company’s executive vice president of product ... when Exo is disrupting the medical imaging space, bringing more than 24 years ...
(Date:5/15/2020)... ... 2020 , ... Sentien Biotechnologies, Inc., a clinical-stage biotechnology company developing novel approaches ... Mr. Ganz will continue to lead Sentien’s Board of Directors, a role he has ... Miller and Sentien’s management team. , Mr. Ganz has more than 30 ...
(Date:5/14/2020)... ... May 13, 2020 , ... Early stages of drug discovery ... no information on the drug’s mechanism of action (MOA). Gene expression profiling technologies ... the activity of molecular pathways. This information can complement phenotypic readouts and can ...
Breaking Biology Technology:
Cached News: